Zobrazeno 1 - 10
of 122
pro vyhledávání: '"H N Claman"'
Autor:
Roy B. Jones, H N Claman, Scott I. Bearman, M. H. Purdy, Wilbur A. Franklin, Elizabeth J. Shpall, Tyler J. Curiel, Philip G. Archer, Salomon M. Stemmer, M. A. Bitter
Publikováno v:
Journal of Clinical Oncology. 12:28-36
PURPOSE To evaluate the capacity of enriched CD34-positive (CD34+) progenitor cells to reconstitute hematopoiesis in poor-prognosis breast cancer patients following administration of a high-dose alkylating agent chemotherapy regimen. PATIENTS AND MET
Autor:
H. N. Claman
Publikováno v:
JAMA: The Journal of the American Medical Association. 268:2790-2796
Autor:
H N, Claman
Publikováno v:
The Pharos of Alpha Omega Alpha-Honor Medical Society. Alpha Omega Alpha. 62(4)
Autor:
H N, Claman, A D, Robertson
Publikováno v:
Current topics in microbiology and immunology. 210
Autor:
A. D. Robertson, H. N. Claman
Publikováno v:
Current Topics in Microbiology and Immunology ISBN: 9783642852282
There has been much controversy about whether women with breast implants are at increased risk for autoimmune disease, particularly scleroderma [1–7]. Associations between breast implants and autoimmunity have been asserted [8–10] nd denied [11
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::34cc62a04a85dbcc96f746ccced7aae8
https://doi.org/10.1007/978-3-642-85226-8_26
https://doi.org/10.1007/978-3-642-85226-8_26
Autor:
H N, Claman
Publikováno v:
JAMA. 268(20)
Autor:
H N, Claman
Publikováno v:
Rheumatic diseases clinics of North America. 16(1)
Mast cells are being recognized as important constituents in fibrotic processes. This article reviews the evidence for increased mast cell numbers and/or function in a variety of fibrotic conditions. Increased mast cell numbers and activity are seen
Publikováno v:
Arthritis & Rheumatism. 33:1448-1448
Autor:
R L Hayes, H N Claman
Publikováno v:
The Journal of Immunology. 130:56-62
We have been studying the regulation of allogeneic cytotoxic cells (CTL) in vivo. CBA/J (H-2k, mls d) responder mice are unable to develop CTL after an allogeneic footpad immunization if they are pretreated i.p. with spleen cells from either C3H/HeN